Ionis Pharmaceuticals: Bull Run Can Continue As Major Catalysts Approach
Ionis Pharmaceuticals is experiencing a significant bull run, with its share price increasing over 125% in the past year. The company remains a strong buy as it approaches major catalysts that could further enhance its market position. Investors are optimistic about the potential for continued growth and innovation in the pharmaceutical sector.
- ▪Ionis Pharmaceuticals' share price has risen more than 125% over the last 12 months.
- ▪The company is considered a strong buy due to upcoming major catalysts.
- ▪Market analysts are optimistic about Ionis' future growth and innovation.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Stock Ideas","item":"https://seekingalpha.com/stock-ideas"},{"@type":"ListItem","position":3,"name":"Long Ideas","item":"https://seekingalpha.com/stock-ideas/long-ideas"},{"@type":"ListItem","position":4,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4909793-ionis-pharmaceuticals-bull-run-can-continue-as-major-catalysts-approach"},"author":{"@type":"Person","name":"Edmund…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
